Blood test could personalize lung cancer treatment, spare some from chemo
NCT ID NCT05715229
Summary
This study is testing if a simple blood test can help doctors better treat advanced non-small cell lung cancer. The test looks for tiny bits of tumor DNA in the blood. Researchers want to see if this test can tell which patients will do well with immunotherapy alone and which might need chemotherapy added to their treatment plan. About 108 adults with newly diagnosed, advanced lung cancer will participate.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jersey Shore University Medical Center
NOT_YET_RECRUITINGNeptune City, New Jersey, 07753, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
-
John Theurer Cancer Center, Hackensack Meridian Health
RECRUITINGHackensack, New Jersey, 07410, United States
Contact Phone: •••-•••-••••
-
Lombardi Comprehensive Cancer Center, Georgetown University
NOT_YET_RECRUITINGWashington D.C., District of Columbia, 20007, United States
Conditions
Explore the condition pages connected to this study.